US20020035071A1
(en)
*
|
1997-07-08 |
2002-03-21 |
Josef Pitha |
Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
|
US8563522B2
(en)
|
1997-07-08 |
2013-10-22 |
The Iams Company |
Method of maintaining and/or attenuating a decline in quality of life
|
US20060116330A1
(en)
*
|
1997-07-08 |
2006-06-01 |
The Iams Company |
Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
|
US7029702B2
(en)
*
|
1998-07-07 |
2006-04-18 |
Ritter Natural Sciences Llc |
Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
|
ID29150A
(id)
*
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
EP1212066A4
(de)
*
|
1999-08-09 |
2004-03-03 |
Univ Maryland |
Pro-intestinale reifung und entzündungshemmende wirkung des lactobacillus und der von lactobacillus sekretierten proteinen, kohlenhydraten und lipiden
|
US20040047868A1
(en)
*
|
2000-07-03 |
2004-03-11 |
Gerald Pang |
Treating endotoxemia and related disorders with probiotics
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
CA2342040C
(en)
*
|
2000-09-21 |
2012-07-10 |
Kyowa Hakko Kogyo Co., Ltd. |
Anaerobic bacterium as a drug for cancer gene therapy
|
EP1593382A1
(de)
|
2000-10-06 |
2005-11-09 |
Société des Produits Nestlé S.A. |
Verwendung von probiotische Milchsäure-produzierende Bakterien zur Beeinflüssung des Immunsystems der Haut
|
IT1320772B1
(it)
*
|
2000-11-02 |
2003-12-10 |
Proge Farm Srl |
Composizione farmaceutica a base di agenti attivi contro la candidaper il trattamento di disturbi della mucosa orale e intestinale
|
EP1371735B1
(de)
*
|
2001-02-01 |
2011-05-04 |
Kabushiki Kaisha Yakult Honsha |
Verfahren zur beurteilung des ausmasses, in dem in lebensmitteln und getränken mit vergorener milch vorhandenes bifidobacterium in den darm gelangt
|
AU2002249531A1
(en)
*
|
2001-04-02 |
2002-10-28 |
Alimentary Health Limited |
Immunotherapy based on dendritic cells
|
JP4671384B2
(ja)
*
|
2001-05-15 |
2011-04-13 |
雪印乳業株式会社 |
新規乳酸菌株
|
EP1264893A1
(de)
*
|
2001-06-08 |
2002-12-11 |
Teagasc Dairy Products Research Centre |
Biosynthese von CLA durch Bifidobakterien
|
US20030092163A1
(en)
*
|
2001-07-26 |
2003-05-15 |
Collins John Kevin |
Probiotic bifidobacterium strains
|
PE20030274A1
(es)
|
2001-07-26 |
2003-05-08 |
Alimentary Health Ltd |
Cepas de lactobacillus salivarius
|
JP5116194B2
(ja)
*
|
2001-09-04 |
2013-01-09 |
株式会社ヤクルト本社 |
炎症性腸疾患予防治療剤
|
US20040241149A1
(en)
*
|
2001-09-05 |
2004-12-02 |
Claudio De Simone |
Use of unmethylatd cpg
|
GB0124580D0
(en)
*
|
2001-10-12 |
2001-12-05 |
Univ Reading |
New composition
|
ATE322538T1
(de)
*
|
2001-12-07 |
2006-04-15 |
Morinaga Milk Industry Co Ltd |
Bifidobacterium longum
|
US6941649B2
(en)
*
|
2002-02-05 |
2005-09-13 |
Force10 Networks, Inc. |
Method of fabricating a high-layer-count backplane
|
DE10206995B4
(de)
*
|
2002-02-19 |
2014-01-02 |
Orthomol Pharmazeutische Vertriebs Gmbh |
Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
|
JP2005537236A
(ja)
*
|
2002-06-13 |
2005-12-08 |
ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド,コーク |
プロバイオティック治療
|
US8168170B2
(en)
|
2002-10-03 |
2012-05-01 |
The Procter And Gamble Company |
Compositions having an inner core and at least three surrounding layers
|
IL152127A0
(en)
|
2002-10-06 |
2003-05-29 |
Bio Balance Corp |
Probiotic compositions for the treatment of inflammatory bowel disease
|
US7105336B2
(en)
*
|
2002-10-07 |
2006-09-12 |
Biogaia Ab |
Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
|
US7740838B2
(en)
*
|
2002-12-05 |
2010-06-22 |
Danisco A/S |
Bacterial composition and its use
|
FR2848115B1
(fr)
*
|
2002-12-05 |
2005-03-25 |
Rhodia Chimie Sa |
Composition de bacteries et son utilisation
|
JP2004189672A
(ja)
*
|
2002-12-11 |
2004-07-08 |
Gen Corp:Kk |
抗下痢症組成物
|
US20040208863A1
(en)
*
|
2003-01-30 |
2004-10-21 |
James Versalovic |
Anti-inflammatory activity from lactic acid bacteria
|
SE526711C2
(sv)
*
|
2003-01-31 |
2005-10-25 |
Probi Ab |
Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
|
US20040197304A1
(en)
|
2003-04-01 |
2004-10-07 |
The Procter & Gamble Company And Alimentary Health, Ltd. |
Methods of determining efficacy of treatments of inflammatory diseases of the bowel
|
US20040265279A1
(en)
*
|
2003-05-08 |
2004-12-30 |
Timothy Dinan |
Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
|
US8192733B2
(en)
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
US7731976B2
(en)
*
|
2003-08-29 |
2010-06-08 |
Cobb And Company, Llp |
Treatment of irritable bowel syndrome using probiotic composition
|
US7749509B2
(en)
*
|
2003-08-29 |
2010-07-06 |
Cobb And Company, Llp |
Treatment of autism using probiotic composition
|
US7759105B2
(en)
*
|
2003-08-29 |
2010-07-20 |
Cobb & Company, Llp |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
US20060177424A1
(en)
*
|
2003-08-29 |
2006-08-10 |
Cobb Mark L |
Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
|
GB0323039D0
(en)
*
|
2003-10-01 |
2003-11-05 |
Danisco |
Method
|
WO2005079210A2
(en)
*
|
2003-12-04 |
2005-09-01 |
Biofilms Strategies, Inc. |
Methods and compositions for preventing biofilm formations, reducing existing biofilms, and for reducing existing biofilms, and for reducing populations of bacteria
|
US8894991B2
(en)
|
2003-12-19 |
2014-11-25 |
The Iams Company |
Canine probiotic Lactobacilli
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
US20050152884A1
(en)
*
|
2003-12-19 |
2005-07-14 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria globosum
|
US7785635B1
(en)
|
2003-12-19 |
2010-08-31 |
The Procter & Gamble Company |
Methods of use of probiotic lactobacilli for companion animals
|
US8877178B2
(en)
*
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
WO2005072718A1
(ja)
*
|
2004-01-28 |
2005-08-11 |
Kurume University |
乳清発酵物を含有する医薬組成物
|
US7862808B2
(en)
*
|
2004-07-01 |
2011-01-04 |
Mead Johnson Nutrition Company |
Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
|
WO2006012536A2
(en)
*
|
2004-07-22 |
2006-02-02 |
Ritter Andrew J |
Methods and compositions for treating lactose intolerance
|
KR100568036B1
(ko)
|
2004-08-12 |
2006-04-07 |
하남주 |
장기능 활성화 및 면역기능 강화작용을 하는비피도박테리움 균주 및 이를 함유하는 생균제제
|
JP2006166829A
(ja)
*
|
2004-12-17 |
2006-06-29 |
Best Ecology:Kk |
アイスサプリメント及びその製造方法
|
WO2006097949A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Actial Farmacêutica, Lda. |
Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
|
AU2011205121B2
(en)
*
|
2005-04-08 |
2012-07-05 |
Alimentary Health Ltd |
Method of use of orally administered probiotic bifidobacteria for human beauty benefits
|
CN101155616A
(zh)
|
2005-04-08 |
2008-04-02 |
宝洁公司 |
用于人类美容有益效果的口服益生菌双歧杆菌的使用方法
|
US20060228448A1
(en)
|
2005-04-11 |
2006-10-12 |
The Iams Company |
Pet food compositions comprising two components
|
US7303745B2
(en)
*
|
2005-04-15 |
2007-12-04 |
Bristol-Myers Squibb Company |
Method for preventing or treating the development of respiratory allergies
|
WO2006130187A1
(en)
|
2005-05-31 |
2006-12-07 |
The Iams Company |
Feline probiotic lactobacilli
|
BRPI0611492B1
(pt)
*
|
2005-05-31 |
2021-10-13 |
Mars, Incorporated |
Bifidobactéria probiótica felina
|
WO2007009568A1
(en)
*
|
2005-07-20 |
2007-01-25 |
Unilever N.V. |
Edible product containing beneficial bacteria
|
ITMI20051510A1
(it)
*
|
2005-08-02 |
2007-02-03 |
Proge Farm Srl |
Uso di specifici batteri lattici per la preparazione di composizioni iunomodulanti
|
RU2297835C1
(ru)
*
|
2005-09-26 |
2007-04-27 |
Закрытое акционерное общество "Партнер" |
Препарат для лечения неинфекционных воспалительных болезней кишечника
|
WO2007038466A2
(en)
*
|
2005-09-27 |
2007-04-05 |
Cobb & Company |
Treatment of bipolar disorder utilizing anti-fungal compositions
|
US7943328B1
(en)
|
2006-03-03 |
2011-05-17 |
Prometheus Laboratories Inc. |
Method and system for assisting in diagnosing irritable bowel syndrome
|
DK2002842T3
(da)
*
|
2006-03-31 |
2012-05-07 |
Morinaga Milk Industry Co Ltd |
Fremgangsmåde til fremstilling af interleukinproduktionsregulator
|
WO2007133188A1
(en)
*
|
2006-05-01 |
2007-11-22 |
Cobb & Company, Llp |
Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
|
US20080085524A1
(en)
|
2006-08-15 |
2008-04-10 |
Prometheus Laboratories Inc. |
Methods for diagnosing irritable bowel syndrome
|
WO2008053444A2
(en)
|
2006-11-01 |
2008-05-08 |
The Procter & Gamble Company |
Treating a respiratory condition with bifidobacterium
|
US7964238B2
(en)
*
|
2007-01-29 |
2011-06-21 |
Guardian Industries Corp. |
Method of making coated article including ion beam treatment of metal oxide protective film
|
CN101711158A
(zh)
|
2007-02-01 |
2010-05-19 |
爱默思公司 |
使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
|
WO2008101450A1
(de)
*
|
2007-02-22 |
2008-08-28 |
Schrezenmeir Juergen |
Probiotische, gram-positive bakterien zur prophylaxe, unterdrückung oder eliminierung von allergischen reaktionen bei menschen
|
RU2468808C2
(ru)
*
|
2007-02-28 |
2012-12-10 |
Мид Джонсон Нутришен Компани |
Способ лечения или предотвращения системного воспаления
|
AU2008230747A1
(en)
*
|
2007-03-27 |
2008-10-02 |
The Procter & Gamble Company |
Methods and kits for administering probiotics
|
KR20100016012A
(ko)
|
2007-03-28 |
2010-02-12 |
앨러멘터리 헬스 리미티드 |
프로바이오틱 비피도박테리움 스트레인
|
BRPI0809448A2
(pt)
|
2007-03-28 |
2014-09-09 |
Alimentary Health Ltd |
Cepas de bifidobacterium probióticas
|
BRPI0811451A2
(pt)
*
|
2007-05-04 |
2014-11-04 |
Alimentary Health Ltd |
Exopolissacarídeo
|
EP2522358B1
(de)
|
2007-06-27 |
2016-11-09 |
Laboratorios Ordesa, S.l. |
Peptide gegen Infektionen mit Rotaviren
|
JP2009057346A
(ja)
*
|
2007-09-03 |
2009-03-19 |
Kirin Holdings Co Ltd |
免疫バランス調節用組成物
|
FR2921795B1
(fr)
*
|
2007-10-03 |
2011-04-29 |
Gervais Danone Sa |
Utilisation d'une souche de bifidobacterium,pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique
|
WO2009068858A1
(en)
*
|
2007-11-26 |
2009-06-04 |
Plant Bioscience Limited |
Novel polypeptides having endolysin activity and uses thereof
|
US20110223248A1
(en)
*
|
2007-12-12 |
2011-09-15 |
Ritter Pharmaceuticals, Inc. |
Methods and compositions for treating lactose intolerance
|
PL2072053T3
(pl)
*
|
2007-12-21 |
2013-02-28 |
Gervais Danone Sa |
Sposób zmniejszania obwodu brzucha przez podawanie bakterii bifidobacterium
|
ES2343499B1
(es)
*
|
2007-12-24 |
2011-06-10 |
Consejo Superior De Investigaciones Cientificas |
Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
|
EP2110028A1
(de)
|
2008-04-15 |
2009-10-21 |
Nestec S.A. |
Bifidobacterium longum und hippocampale BDNF-Expression
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
US20110189148A1
(en)
*
|
2008-06-25 |
2011-08-04 |
Ritter Pharmaceuticals, Inc. |
Lactose compositions with decreased lactose content
|
US9232813B2
(en)
*
|
2008-07-07 |
2016-01-12 |
The Iams Company |
Probiotic supplement, process for making, and packaging
|
CN102089422B
(zh)
*
|
2008-07-11 |
2013-07-17 |
科.汉森有限公司 |
新的益生长双歧杆菌
|
RU2453320C2
(ru)
*
|
2008-08-05 |
2012-06-20 |
Виктор Владимирович Чалов |
Композиция для перорального применения, содержащая непатогенные микроорганизмы, обладающая способностью нормализовать микрофлору кишечника (варианты)
|
US20100233320A1
(en)
*
|
2008-09-11 |
2010-09-16 |
Gregory Dean Sunvold |
Animal Feed Kibble with Protein-Based Core and Related Methods
|
US20100074870A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Bristol-Myers Squibb Company |
Probiotic infant products
|
KR101057357B1
(ko)
|
2008-09-22 |
2011-08-17 |
광주과학기술원 |
유산균 및 콜라겐을 유효성분으로 포함하는 관절염 예방 또는 치료용 약제학적 조성물 및 식품 조성물
|
PL2352389T3
(pl)
*
|
2008-11-11 |
2016-07-29 |
Alimentary Health Ltd |
Bifidobacterium longum
|
BRPI1008280A2
(pt)
|
2009-02-24 |
2015-08-25 |
Ritter Pharmaceuticals Inc |
Formulações prebióticas e métodos mde uso
|
GB0908949D0
(en)
|
2009-05-26 |
2009-07-01 |
Plant Bioscience Ltd |
Novel polypeptides having endolysin activity and uses thereof
|
US20100330151A1
(en)
*
|
2009-06-25 |
2010-12-30 |
Mary Elaine Freeland |
Method of Promoting Gastrointestinal Health Using a Combination of a Probiotic Microorganism and Chocolate
|
US20110027412A1
(en)
|
2009-07-31 |
2011-02-03 |
Kris Eugene Spence |
Compositions and Methods for Promoting Gastrointestinal and/or Cardiovascular Health
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
EP2289527B1
(de)
|
2009-08-25 |
2018-02-21 |
Nestec S.A. |
Bifidobacterium longum und funktionelle GI-Erkrankungen
|
WO2011027829A1
(ja)
*
|
2009-09-02 |
2011-03-10 |
京都府公立大学法人 |
乳酸菌由来のrnaを有効成分とする組成物
|
EP3260126A1
(de)
*
|
2009-10-09 |
2017-12-27 |
Prothera, Inc. |
Zusammensetzungen und verfahren mit pediokokken zur reduzierung mindestens eines symptoms für autismusspektrumserkrankungen bei einem patienten mit diagnostizierter autismusspektrumserkrankung
|
PL2823822T3
(pl)
*
|
2009-11-11 |
2017-09-29 |
Alimentary Health Limited |
Szczep Bifidobakterium
|
ES2595444T3
(es)
*
|
2009-11-11 |
2016-12-30 |
Alimentary Health Limited |
Cepa de Bifidobacterium probiótica
|
ES2437940T3
(es)
*
|
2010-01-28 |
2014-01-15 |
Ab-Biotics S.A. |
Composición probiótica para uso en el tratamiento de la inflamación del intestino
|
HRP20220751T1
(hr)
|
2010-02-01 |
2022-09-02 |
Rebiotix, Inc. |
Bakterioterapija clostridium difficile kolitisa
|
FR2955774A1
(fr)
|
2010-02-02 |
2011-08-05 |
Aragan |
Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
|
CN102884174B
(zh)
*
|
2010-03-26 |
2016-08-03 |
株式会社明治 |
肠道免疫抑制剂的筛选方法
|
RU2451741C2
(ru)
*
|
2010-04-26 |
2012-05-27 |
Татьяна Александровна Левченко |
ШТАММ Bifidobacterium longum АБД-3, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ БИФИДОСОДЕРЖАЩЕЙ ПРОДУКЦИИ
|
RU2451740C2
(ru)
*
|
2010-04-26 |
2012-05-27 |
Татьяна Александровна Левченко |
ШТАММ Bifidobacterium longum АБД-7, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ БИФИДОСОДЕРЖАЩЕЙ ПРОДУКЦИИ
|
EP2563372A4
(de)
|
2010-04-28 |
2013-10-02 |
Ritter Pharmaceuticals Inc |
Präbiotische formulierungen und verwendungsverfahren dafür
|
WO2011148219A1
(en)
*
|
2010-05-28 |
2011-12-01 |
Compagnie Gervais Danone |
Probiotic strains for use in improving the enteric nervous system
|
CN102269858A
(zh)
|
2010-06-02 |
2011-12-07 |
北京智朗芯光科技有限公司 |
自动聚焦***和自动聚焦方法
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性t細胞の増殖または集積を誘導する作用を有する組成物
|
FR2962045B1
(fr)
*
|
2010-07-05 |
2012-08-17 |
Bifinove |
Complexe macromoleculaire d'origine bacterienne et utilisation dudit complexe moleculaire pour prevenir et traiter les rhumatismes inflammatoires
|
SG187713A1
(en)
|
2010-08-04 |
2013-03-28 |
Borody Thomas J |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
AU2011328073A1
(en)
*
|
2010-11-11 |
2013-05-02 |
Nestec S.A. |
Frozen confections containing probiotic micro-organisms
|
PL2481299T3
(pl)
|
2011-01-31 |
2017-09-29 |
Synformulas Gmbh |
Szczepy bifidobacterium bifidum do stosowania w chorobach przewodu pokarmowego
|
ES2636439T3
(es)
|
2011-03-09 |
2017-10-05 |
Regents Of The University Of Minnesota |
Composiciones y métodos para el trasplante de microbiota de colon
|
WO2012140636A1
(en)
*
|
2011-04-11 |
2012-10-18 |
Alimentary Health Limited |
A probiotic formulation
|
RU2460777C1
(ru)
*
|
2011-04-21 |
2012-09-10 |
Общество с ограниченной ответственностью "Бифилюкс" |
Штамм bifidobacterium longum, используемый для получения бифидосодержащей продукции
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
KR101355440B1
(ko)
|
2011-10-26 |
2014-02-05 |
주식회사한국야쿠르트 |
류마티스 관절염 예방 효능을 갖는 락토바실러스 헬베티쿠스 에이취와이7801 및 이를 유효성분으로 함유하는 제품
|
CN103131647B
(zh)
*
|
2011-11-29 |
2017-06-27 |
上海上药信谊药厂有限公司 |
婴儿双歧杆菌及其制剂
|
CN108676774B
(zh)
|
2011-12-01 |
2023-05-09 |
国立大学法人东京大学 |
诱导调节性t细胞的增殖或积累的人源细菌
|
US9856451B2
(en)
|
2011-12-28 |
2018-01-02 |
Yamada Bee Company Inc. |
Lactic acid bacterium having IgA production promoting activity, and use thereof
|
EP2828375B1
(de)
|
2012-01-19 |
2017-11-22 |
University College Cork-National University of Ireland, Cork |
Gaba-erzeugende, aus dem menschlichen magen-darm-trakt stammende kultivierbare bakterie
|
CN108771687A
(zh)
|
2012-02-29 |
2018-11-09 |
伊西康内外科公司 |
微生物区系的组合物及与其相关的方法
|
US10588857B2
(en)
|
2012-03-29 |
2020-03-17 |
Therabiome, Llc |
Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
WO2014031553A1
(en)
|
2012-08-20 |
2014-02-27 |
Markosian Boris |
Placental vaccination therapy for cancer
|
FR2999601B1
(fr)
*
|
2012-12-17 |
2015-01-30 |
Urgo Lab |
Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
|
JP6464142B2
(ja)
|
2013-03-14 |
2019-02-06 |
セラバイオーム,エルエルシー |
プロバイオティクス生物及び/又は治療剤の標的化胃腸管デリバリー
|
KR101434220B1
(ko)
*
|
2013-03-26 |
2014-08-28 |
삼육대학교산학협력단 |
다제내성균에 대한 저해 활성을 갖는 신규 유산균
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
US10383901B2
(en)
|
2013-06-05 |
2019-08-20 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9511100B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9694039B2
(en)
|
2013-06-05 |
2017-07-04 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9782445B2
(en)
|
2013-06-05 |
2017-10-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
CA2914636C
(en)
|
2013-06-05 |
2021-04-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (mrt), compositions and methods of manufacture
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US10633714B2
(en)
|
2013-07-21 |
2020-04-28 |
Pendulum Therapeutics, Inc. |
Methods and systems for microbiome characterization, monitoring and treatment
|
JP2017511708A
(ja)
|
2014-01-24 |
2017-04-27 |
ザ プロクター アンド ギャンブル カンパニー |
微生物含有繊維要素を含むウェブ及びその作製方法
|
CA2935942A1
(en)
|
2014-01-24 |
2015-07-30 |
The Procter & Gamble Company |
Filaments comprising a microorganism and method for making same
|
US20150209468A1
(en)
|
2014-01-24 |
2015-07-30 |
The Procter & Gamble Company |
Hygiene article containing microorganism
|
CA2964480A1
(en)
|
2014-10-31 |
2016-05-06 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
LT3065748T
(lt)
|
2014-12-23 |
2018-03-12 |
4D Pharma Research Limited |
Bacteroides thetaiotaomicron padermė ir jos panaudojimas uždegimo sumažinimui
|
HUE037476T2
(hu)
|
2014-12-23 |
2018-08-28 |
4D Pharma Res Ltd |
Pirin polipeptid és immunmodulálás
|
MX2017010321A
(es)
|
2015-02-13 |
2017-12-07 |
Mars Inc |
Sistema de alimentacion para mascotas.
|
US11388914B2
(en)
|
2015-04-28 |
2022-07-19 |
Mars, Incorporated |
Process of preparing a wet pet food, wet pet food produced by the process and uses thereof
|
KR102561989B1
(ko)
|
2015-05-14 |
2023-07-31 |
핀치 테라퓨틱스 홀딩스 엘엘씨 |
대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치
|
DK3297644T3
(da)
|
2015-05-22 |
2022-04-11 |
Univ Arizona State |
Fremgangsmåder til behandling af autismespektrumforstyrrelse og forbundne symptomer
|
MX2017015473A
(es)
|
2015-06-01 |
2018-08-15 |
Univ Chicago |
Tratamiento contra el cancer por manipulacion de la microflora comensal.
|
US20160354507A1
(en)
|
2015-06-07 |
2016-12-08 |
The Procter & Gamble Company |
Article of commerce containing absorbent article
|
US10905726B2
(en)
|
2015-06-09 |
2021-02-02 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10799539B2
(en)
|
2015-06-09 |
2020-10-13 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
IL281424B2
(en)
|
2015-06-09 |
2023-10-01 |
Rebiotix Inc |
Microbiota restoration treatment preparations and production methods
|
US10828340B2
(en)
|
2015-06-09 |
2020-11-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
RS59308B1
(sr)
|
2015-06-15 |
2019-10-31 |
4D Pharma Res Ltd |
Kompozicije koje sadrže bakterijske sojeve
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
EP3636272A1
(de)
|
2015-06-15 |
2020-04-15 |
4D Pharma Research Limited |
Zusammensetzungen mit bakterienstämmen
|
LT3650033T
(lt)
|
2015-06-15 |
2022-04-11 |
4D Pharma Research Limited |
Kompozicijos, apimančios bakterinius kamienus
|
US20170020750A1
(en)
|
2015-07-23 |
2017-01-26 |
The Procter & Gamble Company |
Patch containing microorganism
|
EP3341081B1
(de)
|
2015-08-27 |
2020-11-11 |
PrecisionBiotics Group Limited |
Verwendung von bifidobakterium longum sowie einem hiervon gewonnenen exopolysaccharid
|
AU2016312624B2
(en)
|
2015-08-27 |
2019-02-07 |
Alimentary Health Ltd. |
Bifidobacterium longum
|
JP2018534277A
(ja)
|
2015-10-05 |
2018-11-22 |
シュヴァイツェリッシェ フォルシュングスインスティテュート フュア ホーフゲブリクスクリーマ ウント メディツィン イン ダヴォス |
炎症性状態を治療するためのアッカーマンシア・ムシニフィラ(Akkermansia muciniphila)の使用
|
GB2561748B
(en)
|
2015-11-20 |
2019-05-08 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
US10913053B2
(en)
*
|
2016-03-04 |
2021-02-09 |
California Institute Of Technology |
Germanosilicate compositions and methods of preparing the same
|
TW201733601A
(zh)
|
2016-03-04 |
2017-10-01 |
4D製藥有限公司 |
包含細菌菌株之組合物
|
RU2659240C2
(ru)
*
|
2016-05-23 |
2018-06-29 |
федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский государственный университет" (КемГУ) |
Способ получения функционального продукта питания для реабилитации онкологических больных
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
TWI802545B
(zh)
|
2016-07-13 |
2023-05-21 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
WO2018071537A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
US11213549B2
(en)
|
2016-10-11 |
2022-01-04 |
Finch Therapeutics Holdings Llc |
Compositions and method for treating primary sclerosing cholangitis and related disorders
|
IT201600121481A1
(it)
*
|
2016-11-30 |
2018-05-30 |
Sintal Dietetics Srl |
L. salivarius sgl03: attività probiotiche e produzione di proteine antimicrobiche
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
CN107043705A
(zh)
*
|
2016-12-30 |
2017-08-15 |
大连医科大学 |
用于建立临床营养菌种资源库的益生菌筛选方法
|
SG11201907043VA
(en)
*
|
2017-01-31 |
2019-08-27 |
Univ Industry Cooperation Group Kyung Hee Univ |
Novel lactic acid bacteria and use thereof
|
US11590179B2
(en)
|
2017-02-28 |
2023-02-28 |
Precisionbiotics Group Limited |
Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
|
CN110831606A
(zh)
|
2017-04-05 |
2020-02-21 |
克雷斯顿沃控股公司 |
治疗帕金森氏病(pd)和相关疾病的组合物和方法
|
US11040073B2
(en)
|
2017-04-05 |
2021-06-22 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
MA48940A
(fr)
|
2017-05-22 |
2020-04-08 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
EP3630942B1
(de)
|
2017-05-24 |
2022-11-30 |
4D Pharma Research Limited |
Zusammensetzungen mit bakterienstamm
|
WO2018218159A1
(en)
|
2017-05-26 |
2018-11-29 |
Crestovo Holdings Llc |
Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
|
DK3804737T3
(da)
|
2017-06-14 |
2022-07-25 |
4D Pharma Res Ltd |
Sammensætninger omfattende bakteriestammer
|
MD3638271T2
(ro)
|
2017-06-14 |
2021-03-31 |
4D Pharma Res Ltd |
Compoziții cuprizând tulpini bacteriene
|
AR112328A1
(es)
|
2017-07-05 |
2019-10-16 |
Evelo Biosciences Inc |
Composiciones y métodos para tratamiento de cáncer usando bifidobacterium animalis ssp. lactis
|
AU2018313766A1
(en)
*
|
2017-08-07 |
2020-02-20 |
Finch Therapeutics, Inc. |
Compositions and methods for maintaining and restoring a healthy gut barrier
|
CN111372596A
(zh)
|
2017-08-30 |
2020-07-03 |
潘德勒姆治疗公司 |
用于治疗微生物组相关病症的方法和组合物
|
RU2665173C1
(ru)
*
|
2017-09-18 |
2018-08-28 |
Федеральное государственное бюджетное образовательное учреждение высшего образования "Оренбургский государственный медицинский университет" Министерства здравоохранения Российской Федерации |
Способ профилактики атопического дерматита у младенцев путем модуляции микробного механизма гистаминообразования
|
US20200338144A1
(en)
*
|
2017-11-01 |
2020-10-29 |
Biofermin Pharmaceutical Co., Ltd. |
Agent for preventing or treating small intestinal injury induced by non-steroidal anti-inflammatory drug and proton pump inhibitor
|
KR102024883B1
(ko)
|
2017-11-24 |
2019-09-24 |
주식회사 고바이오랩 |
락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도
|
DK3517119T3
(da)
|
2018-01-26 |
2021-11-15 |
Probisearch S L U |
Sammensætning omfattende ny lactobacillus salivarius-stamme og fremgangsmåde til forebyggelse og behandling af otitis og infektioner i de øvre luftveje
|
ES2933999T3
(es)
*
|
2018-01-29 |
2023-02-15 |
Prec Group Limited |
Un producto combinado para la profilaxis y el tratamiento del síndrome del intestino irritable
|
US11825856B2
(en)
*
|
2018-03-28 |
2023-11-28 |
Morinaga Milk Industry Co., Ltd. |
Composition for preventing or improving functional gastrointestinal disorders, and, pharmaceutical composition, food/beverage composition, and method of preventing or improving functional gastrointestinal disorders using the composition for preventing or improving functional gastrointestinal disorders
|
RU2670054C1
(ru)
*
|
2018-04-24 |
2018-10-17 |
Федеральное государственное бюджетное учреждение науки Институт клеточного и внутриклеточного симбиоза Уральского отделения Российской академии наук |
Штамм бактерий Bifidobacterium bifidum ICIS-310 - продуцент ингибитора провоспалительного цитокина INF-γ
|
WO2019216662A1
(ko)
|
2018-05-09 |
2019-11-14 |
주식회사 고바이오랩 |
락토바실러스 파라카제이 균주 및 그 용도
|
CN113151036A
(zh)
*
|
2018-05-11 |
2021-07-23 |
韩国亿诺生物有限公司 |
具有预防或治疗癌症的效果的新型菌株
|
CN112469812B
(zh)
|
2018-05-23 |
2024-01-12 |
Ko生物技术有限公司 |
格氏乳杆菌kbl697菌株及其用途
|
CN112236154A
(zh)
*
|
2018-05-31 |
2021-01-15 |
深圳华大生命科学研究院 |
一种组合物及其应用
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
CN109486700A
(zh)
*
|
2018-08-31 |
2019-03-19 |
石家庄君乐宝乳业有限公司 |
副干酪乳杆菌n1115预防结肠炎的应用及相应的益生菌粉、应用
|
WO2020069280A1
(en)
|
2018-09-27 |
2020-04-02 |
Crestovo Holdings Llc |
Compositions and methods for treating epilepsy and related disorders
|
ES2752798B2
(es)
*
|
2018-10-05 |
2020-08-12 |
Consejo Superior Investigacion |
Cepa de Bifidobacterium longum sub. infantis y uso de la misma
|
KR102074445B1
(ko)
*
|
2018-12-12 |
2020-02-06 |
주식회사 비피도 |
류마티스관절염 개선, 예방 또는 치료를 위한 비피도박테리움 롱검 rapo 균주 및 이를 포함하는 조성물
|
WO2021021765A1
(en)
*
|
2019-07-26 |
2021-02-04 |
Evolve Biosystems, Inc. |
Nutritive compositions with bioactive proteins
|
KR102224072B1
(ko)
*
|
2019-08-19 |
2021-03-10 |
주식회사 빙그레 |
면역 조절능력과 혈중콜레스테롤 감소 능력이 모두 뛰어난 비피도박테리엄 롱검 아종 균주 및 이의 용도
|
CN110547915A
(zh)
*
|
2019-08-29 |
2019-12-10 |
云南白药清逸堂实业有限公司 |
应用益生菌的卫生棉制品及其制备方法
|
CN110452860A
(zh)
*
|
2019-09-24 |
2019-11-15 |
厦门大学 |
一种唾液链球菌及其在治疗炎症性肠病药物中的应用
|
WO2021180973A1
(en)
|
2020-03-13 |
2021-09-16 |
Precisionbiotics Group Limited |
Bifidobacterium longum
|
TWI748395B
(zh)
*
|
2020-03-31 |
2021-12-01 |
豐華生物科技股份有限公司 |
緩解過敏以及提升運動表現之組合物及其用途
|
CN113943681B
(zh)
*
|
2020-11-12 |
2023-07-04 |
江南大学 |
一株降低炎症反应且具有缓解便秘作用的长双歧杆菌
|
KR102307603B1
(ko)
*
|
2020-11-13 |
2021-10-05 |
주식회사 비피도 |
비피도박테리움 롱검 rapo (kctc13773bp)를 포함하는 암 예방 또는 치료용 조성물
|
CN114317310B
(zh)
*
|
2021-03-31 |
2023-09-22 |
江苏蓝泽生物科技有限公司 |
一种抗过敏的婴儿双歧杆菌制剂及其制备方法
|
CN114558037B
(zh)
*
|
2022-02-24 |
2023-08-15 |
同济大学 |
Akk和ls在制备提高认识水平的抗衰老产品中的应用
|
CN115725456B
(zh)
*
|
2022-10-11 |
2024-06-21 |
四川大学 |
一种唾液乳杆菌及其应用
|